Evidence map›Paper›PMID 40559109›Full record

ArticleJournal of personalized medicine2025

Assessing the Impact of Simplified Language on a Patient-Facing Pharmacogenetic Report: A User Comprehension Study.

Russell Amato, Nicole M Del Toro-Pagan, Harris Nguyen, Jordan Plummer, Katie Pizzolato, David Krause, Daniel Dowd

Abstract read
In one paragraph

Article in Journal of personalized medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Russell AmatoClinical Research & Development and Medical Affairs, Genomind, Inc., King of Prussia, PA 19406, USA.ORCID 0009-0006-8867-5265
Nicole M Del Toro-PaganClinical Research & Development and Medical Affairs, Genomind, Inc., King of Prussia, PA 19406, USA.ORCID 0000-0002-5399-5940
Harris NguyenClinical Research & Development and Medical Affairs, Genomind, Inc., King of Prussia, PA 19406, USA.
Jordan PlummerClinical Research & Development and Medical Affairs, Genomind, Inc., King of Prussia, PA 19406, USA.ORCID 0009-0006-7502-819X
Katie PizzolatoClinical Research & Development and Medical Affairs, Genomind, Inc., King of Prussia, PA 19406, USA.
David KrauseClinical Research & Development and Medical Affairs, Genomind, Inc., King of Prussia, PA 19406, USA.
Daniel DowdClinical Research & Development and Medical Affairs, Genomind, Inc., King of Prussia, PA 19406, USA.ORCID 0000-0003-3383-6800

Funding

Development of a Patient-Facing Portal for the Receipt, Interpretation and Tracking Utility of Pharmacogenetic (PGx) DataR43HG013068 · NHGRI · GENOMIND, INC. · PI DOWD, DANIEL F · 2023 to 2023
$400k
National Human Genome Research Institute of the National Institutes of Health R43HG013068NHGRI NIH HHS R43 HG013068
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

CYP450health literacymedication managementmedication safetypatient-centered carepharmacogeneticspharmacogenomicsprecision medicine

Identifiers

PMID40559109
PMCPMC12194072

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.